Senolytica Raises $500M to Commercialize AI-Discovered Senolytic Drug Following Phase 2 Success
Senolytica has raised $500M in Series C funding to commercialize SNS-01, an AI-discovered senolytic drug that successful...
Read More →Latest news and updates from this category.
Senolytica has raised $500M in Series C funding to commercialize SNS-01, an AI-discovered senolytic drug that successful...
Read More →DirectAir has achieved negative-cost carbon capture using a novel solar-driven Metal-Organic Framework (MOF), generating...
Read More →Edge AI startup AetherCompute has raised a $1.5B Series D at a $12B valuation to scale its liquid-cooled micro-datacente...
Read More →Driven by the massive energy demands of the AI boom, the 2026 startup ecosystem is experiencing a "Hard Tech Renaissance...
Read More →In June 2026, the startup ecosystem is undergoing a massive correction, pivoting from passive generative AI to autonomou...
Read More →FinTech startup AegisFi has launched the first federally insured crypto-custody platform for traditional banks, allowing...
Read More →Biotech startup Aevum Therapeutics has launched the first human clinical trials for its cellular rejuvenation therapy, w...
Read More →Fusion startup Helion Energy has signed a historic $2 billion power purchase agreement with Microsoft to deliver electri...
Read More →Varda Space Industries successfully returned the first commercial payload of microgravity-manufactured pharmaceuticals t...
Read More →Silicon Valley startup Nexus Agents has raised $500 million to scale its autonomous AI software engineers that can write...
Read More →